Cargando…
Pharmacological Treatment for Social Cognition: Current Evidence
Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it...
Autores principales: | Riccardi, Cecilia, Montemagni, Cristiana, Del Favero, Elisa, Bellino, Silvio, Brasso, Claudio, Rocca, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307511/ https://www.ncbi.nlm.nih.gov/pubmed/34299076 http://dx.doi.org/10.3390/ijms22147457 |
Ejemplares similares
-
The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives
por: Del Favero, Elisa, et al.
Publicado: (2021) -
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2017) -
Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients With Schizophrenia
por: Montemagni, Cristiana, et al.
Publicado: (2021) -
The relative contributions of insight and neurocognition to intrinsic motivation in schizophrenia
por: Brasso, Claudio, et al.
Publicado: (2022) -
Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset
por: Brasso, Claudio, et al.
Publicado: (2021)